Glenmark Pharmaceuticals receives USFDA tentative approval for Regadenoson Injection

20 Jan 2022 , 01:35 AM

Glenmark Pharmaceuticals Inc USA Glenmark has received tentative approval by the United States Food Drug Administration US FDA for Regadenoson Injection 04 mg5 mL 008 mgmL Single-Dose Pre-Filled Syringe the generic version of Lexiscan1 Injection 04 mg5 mL 008 mgmL of Astellas US Inc According to IQVIATM sales data for the 12 month period ending November 2021 the Lexiscan Injection 04 mg5 mL 008 mgmL market achieved annual sales of approximately $6599 million